Michael Harrington to Skin Neoplasms
This is a "connection" page, showing publications Michael Harrington has written about Skin Neoplasms.
Connection Strength
1.340
-
The impact of neoadjuvant hedgehog inhibitor therapy on the surgical treatment of extensive basal cell carcinoma. Ann Plast Surg. 2015 Jun; 74 Suppl 4:S193-7.
Score: 0.409
-
Neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma: an investigator-initiated, open-label phase II trial. J Immunother Cancer. 2026 Jan 14; 14(1).
Score: 0.213
-
Recurrence and Survival Outcomes in Patients with Primary Merkel Cell Carcinoma with Positive, Negative, or Not Performed Sentinel Lymph Node Biopsy. Ann Surg Oncol. 2026 Jan; 33(1):389-396.
Score: 0.210
-
Atypical Fibroxanthoma: Outcomes from a Large Single Institution Series. Cancer Control. 2023 Jan-Dec; 30:10732748231155699.
Score: 0.173
-
Treatment of Head and Neck Melanoma In Situ With Staged Contoured Marginal Excisions. Ann Plast Surg. 2017 Jun; 78(6):663-667.
Score: 0.117
-
Epidermal programmed cell death-ligand 1 expression in TEN associated with nivolumab therapy. J Cutan Pathol. 2017 Apr; 44(4):381-384.
Score: 0.115
-
Cutaneous angiosarcoma. Curr Probl Cancer. 2015 Jul-Aug; 39(4):258-63.
Score: 0.103